Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Clonal evolution underlying clinical responses and relapses in subjects with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine


Dylan Marchione, PhD
Description

At this year’s World CB & CDx conference held in Boston, Dylan Marchione, PhD, of Servier Pharmaceuticals presented data supporting the use of the Tapestri Platform in clinical development to elucidate clonal evolution patterns in patients with IDH1-mutated AML treated with combination therapy, TIBSOVO + azacitidine, as compared to monotherapy.



VIEW


Scientific presentation
From Stealth to Spotlight: Single-Cell Identification of SMM Clones Driving Myeloma Progression and Therapy Resistance
Adam Sciambi, PhD
(2024)
Scientific presentation
Multiplexing 101: Unlocking Critical Single-Cell Insights with Increased Throughput and Efficiency
Jacqueline Marin
(2024)
Scientific presentation
Single-cell Multi-omics for Discovery, Translational, and Clinical Development
Gema Fuerte, PhD
World CDx Europe (2024)
Scientific presentation
Confidently Validate Cancer Models for Precision Medicine
Dr. Robert Bowman
Divya Rao
(2024)
REQUEST QUOTE